Navigation Links
Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Date:7/23/2009

VANCOUVER, July 23 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today filed a preliminary short form base shelf prospectus with the securities commissions of British Columbia and Ontario and a corresponding shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (collectively, the "Offering Documents"). The Offering Documents, when made final and / or declared effective, will allow Angiotech to make offerings of Common shares, Class I Preference shares, debt securities, warrants or units for initial aggregate proceeds of up to US$250 million during the next 25 months to potential purchasers in British Columbia, Ontario and the United States. Angiotech intends to use the proceeds from any such offering for general corporate purposes, including funding research and development programs, capital expenditures, working capital and/or repayment or refinancing of the Company's outstanding indebtedness, except as otherwise indicated in the applicable prospectus supplement related to any such offering.

A registration statement relating to these securities has been filed with the United States Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

    Forward Looking Statements
    --------------------------

Statements contained in this press release that are not based on historical
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  David Hardison, Ph.D., vice president ... , has been elected chairman of the board ... non-profit working to establish common protocols around the ... relates to electronic health records. ... collaborating with organizations across the research and health ...
(Date:7/28/2014)... , July 28, 2014   Propeller Health ... disease, announced the hire of Brad Towle ... will be responsible for driving the company,s sales growth, ... experience in healthcare, and specifically his past role in ... to the company at this pivotal time in the ...
(Date:7/28/2014)... It’s a hard truth: Nearly half of ... their post-secondary education are failing to obtain a diploma or ... And according to an analysis by The Resume Place ... uninformed choice of college majors, which leads to underemployment, unemployment ... Some 51.7 percent of post-9/11 veterans using GI Bill ...
(Date:7/28/2014)... -- InterMune, Inc. (NASDAQ: ITMN ) today announced ... results at the close of the U.S. markets on ... will be hosted by InterMune at 4:30 p.m. Eastern ... others may participate in the conference call by dialing ... of the webcast and teleconference will be available on ...
Breaking Biology Technology:ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4InterMune to Release Second Quarter Financial Results on August 6 2
... According to a new market research report, "Seed ... by MarketsandMarkets ( http://www.marketsandmarkets.com ), global seed treatment market ... This growth is fueled by government encouragement for adoption ... is particularly higher in geographies such as Latin America ...
... Jan. 9, 2012 Reportlinker.com announces ... is available in its catalogue: , ... Transplantation, Cord Blood Banking and Drug ... There is great interest ...
... Jan. 8, 2012 Sequenom, Inc. (NASDAQ: SQNM ... today announced highlights of the Company,s 2011 performance and accomplishments, ... part of 2012. Initial 2011 Performance ... 23 percent year-over-year for 2011 (unaudited). , Over 21,000 ...
Cached Biology Technology:MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016 2MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016 3Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 2Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 3Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 4Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 5Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 6Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 2Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 3Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 4
(Date:7/28/2014)... South Pole in 1911, but new research shows that ... Using data from 16 ice cores collected from widely ... Pole, a group led by Joe McConnell of the ... most accurate and precise reconstruction to date of lead ... in an article published today in the online edition ...
(Date:7/28/2014)... and organic compounds in hydrothermal environments are critical components ... for the deep biosphere, and may have implications for ... about how minerals influence organic reactions. A team ... a common mineral acts as a catalysts for specific ... solvents or expensive reagents. , At the heart of ...
(Date:7/28/2014)... A study of juvenile rat brain cells suggests that ... the connections between brain cells are temporary. , The ... PLOS ONE , was conducted by biologists at ... Medical College in New York in response to concerns, ... decade, that exposing children to general anesthetics may increase ...
Breaking Biology News(10 mins):Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3
... Vincetoxicum rossicum ) is an exotic plant originating ... increasingly invasive in southern Ontario, Canada. It has been ... in open fields, forest edges and understories, parks, road ... for light by forming large and dense stands that ...
... Crusafont Catalan Palaeontology Institute has for the first time documented ... Narg archaeological site in Lleida, Spain. Up until now, only ... region. , The archaeological site in Coll de Narg containing ... the town that bears the same name in the province ...
... Alex Pyron,s expertise is in family trees. Who is related ... they are now. But not for humans: reptiles. In ... the island led him to confirm the identity of 60 ... an author on snakes and expert on amphibians and reptiles, ...
Cached Biology News:A European invader outcompetes Canadian plants even outside its usual temperature range 24 dinosaur egg species identified in Lleida 2Sri Lankan snake study reveals new species, rich biodiversity in island country 2
normal human fibroblasts Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
A431 cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
PC12 (rat phaeochromocytoma) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: